Compañía
Letter from the Chair
Letter from the CEO
2024 Highlights
Investor Information
Our Priorities in 2024
Our People and Culture
Our Businesses
Group Operations
Productos biológicos
Moléculas pequeñas
Células y genes
Cápsulas e ingredientes para la salud
Sustentabilidad
Financials
Remuneration
Governance
Creating Value in 2024
Creating Value in 2024
Our Businesses
Our Approach to Sustainability
Financial Highlights
Corporate Governance Overview
Creating Value in 2024
Download Section PDF
